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Matrix tablets of Prednisolone were prepared by wet granulation method using various proportions of 
Sterculia gum with Carbopol 934P and Sterculia gum with Ethyl cellulose at 1:1, 1: .5 and 1:2 ratio. Coating 
was carried out by using 1:1 ratio of Eudragit L100 and Eudragit S100. All the preparation were evaluated for 
Pre compressional properties, Post compressional properties and in-vitro Dissolution study in different pH 
buffer of 0.1N HCL ,pH 7.4 , pH 6.8 in order to mimic GIT condition. Formulation shows good results with 
good percentage yield. 
Keywords: Colon targeted, Ethyl Cellulose, Carbopol 934p , Sterculia gum , wet granulation, Crohn’s 
disease.  
 
INTRODUCTION 
Colon Targeted Drug Delivery System (CTDDS) may 
be follow the concept of Controlled or Sustained drug 
Delivery System. For CTDDS oral route of 
administration has received most attention. Local 
delivery allows topical treatment of inflammatory bowel 
disease. Colon is highly desirable for local treatment of 
a variety of bowel diseases such as ulcerative colitis, 
Crohn’s disease, amebiosis, colonic cancer, local 
treatment of colonic pathologies, and systemic delivery 
of protein and peptide drugs[1,2]. For effective  and safe 
therapy of these colonic disorders, colon specific drug 
delivery is necessary i.e. drug release and absorption 
should not occur in the stomach as well as the small 
intestine, and neither the bioactive agent should be 
degraded in either of the dissolution sites but only 
released and absorbed once the system reaches the colon 
[3]. Today, colon specific drug delivery is challenging 
task to pharmaceutical technologist. The colon is 
believed to be a suitable absorption site for peptides and 
protein drugs for the following reasons, (i) less 
diversity, and intensity of digestive enzymes, (ii) 
comparative proteolytic activity of colon mucosa is 
much less than that observed in the small intestine, thus 
CDDS protects peptide drugs from hydrolysis, and 
enzymatic degradation in duodenum and jejunum, and 
eventually releases the drug into ileum or colon which 
leads to greater systemic bioavailability[4]. The 
concentration of drug reaching the colon depends on 
formulation factors, the extent of retrograde spreading 
and the retention time[5]. Coating of the drugs with pH-
sensitive polymers provides simple approach for colon-
specific drug delivery[6]. The bioactive agent should be 
degraded in either of the dissolution sites but only 
released and absorbed once the reaches the colon. 
Because the colon has a long residence time 72 hours 
and high water content it favors absorption of poorly 
absorbed drug molecule may have an improved 
bioavailability, CDDS has been employ to achieve 
following objectives i) Sustained delivery to reduce 
dosing frequency ii) Delay deliver of drug to achieve 
high concentration in treatment of disease of distal gut 
iii) to delay deliver to a time appropriate to treat acute 
phase of disease iv) Deliver drug to that region that is 
less hostile metabolically, drug which is acid and 
enzyme labile such as proteins[7]. The upper part of 
GIT, i.e. the stomach and the duodenum has a 
microflora of less than 103 _ 104 CFU/ml. The microflora 
of colon on the other side is in the range of 1011_1012 
CFU/ml consisting mainly of anaerobic bacteria, e.g. 
Bacteroides, Bifidobacteria, Eubacteria, Clostridia, 
Enterococci, Enterobacteria, etc.    
This vast microflora fulfils its energy needs by 
fermenting various types of substrates that have been 
left undigested in the small intestine, e.g, di and 
trisaccharides, polysaccharide etc. For this fermentation, 
the microflora produces a vast number of enzymes like 
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glucuronidase, xylosidase, arabinosidase, galactosidase, 
nitroreductase, azoreductase, deaminase and urea 
dehydroxylase . Because of the presence of these 
biodegradable enzymes only in the colon, the use of 
bacterial degradable polymers for colon specific drug 
delivery seems to be a more site specific approach as 
compared to other approaches. This study given the idea 
to evaluate the usefulness of Sterculia gum as carrier 
using  Prednisolone as drug. Sterculia gum is a complex 
polysaccharide of high molecular weight. A molecular 
weight as high as 9,500,000 and viscosity of 1% 
solution is CPS >1100 has been reported. On hydrolysis 
it yields Galactose, Rhamnose, and Galacturonic acid. 
The present research work aimed to develop the 
sterculia gum colon specific  tablet in combination with 
carbopol 934 P and ethyl cellulose at various 
proportions by wet granulation technology. To study the 
physical integrity up to 24 h and the in vitro dissolution 
to explore the application of sterculia gum as drug 
carrier in colon matrix tablet. 
 
MATERIAL AND METHODS 
Material   
Prednisolone as gift sample obtained from Emcross 
pharmachem, Roorkee. Sterculia gum Carbopol 934 P, 
Ethyl cellulose, magnesium sterate and talc obtained 
from Central drug house Pvt Ltd. New Delhi. 
 
Method of preparation of Prednisolone tablet for colon  
The ingredients required to prepare a batch of tablets as 
given in formula (table 1) were weighed accurately and 
passed through # 120 mesh sieve and uniformly blended 
in a mortar. Starch pastes were prepared. The powder 
blend was taken in a mortar and was thoroughly 
triturated with starch paste to produce wet mass. Then 
wet mass was passed through mesh # 14. Granules so 
obtained were dried at 40°C for 2 h. Dried granules 
again passed through mesh # 18. Later, talc and 
magnesium sterate were added as required and blended. 
Then the granules are evaluated for rheological 
characteristics. The dried granules were compressed 
into tablet using a 10 station Tablet pilot press. 
Evaluation of precompressional characteristics of 
Prednisolone 
Bulk granular density 
50 g of powder from each formulation was introduced 
into a 100 ml measuring cylinder. Initial volume was 
observed, the cylinder was allowed to tap. The tapping 
was continued until no further change in volume was 
noted. Bulk density is calculated by using formula: 
Bulk density  ρb =
Bulk volume of the powder
Weight of the powder 
 
Tapped granular density 
Tapped granular density determine by tapping method, 
here 50g of the granules (W) was introduced into a 
100ml measuring cylinder, The cylinder was allowed to 
fall under its own weight onto a hard surface from the 
height of 1 inch at 2 sec intervals. The tapping was 
continued until no further change in volume was noted. 
The bulk density and tapped density were calculated 
using the following formulae. 
Tapped density  ρt =
Tapped volume of the powder
Weight of the powder 
 
 
Carr’s index [Compressibility Index] & Hausner’s 
Ratio: 
The carr’s index of the powder was determined by using 
formula: 
Carr’s index % 
=
Tapped Granular density −  Bulk Granular density
Tapped density
x100 
Hausner’s ratio =
Tapped Granular density 
Bulk Granular density 
 
 
Angle of repose 
The angle of repose of blend was determined by the 
funnel method. The accurately weight power was taken 
in a funnel. The height of the funnel was adjusted in 
such a way that the tip of the funnel just touches the 
apex of the heap of the power. The powder was allowed 
to flow through the funnel freely onto the surface. The 
diameter of the powder cone was measured and angle of 
repose was calculated using the following equation 
θ = tan−1
h
r
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Table I: Preparation of tablet 
Ingredient F1 F2 F3 F4  F5 F6 
Drug  50 50 50 50 50 50 
Sterculia 
gum 
150 150 200 200 100  100 
Carbopol 
934p  
150  100  200  
Ethyl 
cellulose  
 150  100  200 
Talc  25 25 25 25 25 25 
Mg. 
Sterate  
25  25 25 25 25 25 
 
Evaluation of Prednisolone tablets  
Weight uniformity  
Twenty tablets were taken and weighed individu-ally. 
Average weight was calculated standard deviation and 
percent coefficient of variance was computed.  
Thickness test  
The tablets were evaluated for their thickness using a 
micrometer (Mitutoyo, Japan). Average of three 
readings was taken and the results were tabulated (n=3)  
Diameter test  
The tablets were evaluated for diameter using a 
micrometer (Mitutoyo, Japan). Average of three 
readings were taken and tabulated (n = 3).  
Hardness test  
The tablets were evaluated for their hardness using 
Pfizer hardness tester. Average of three reading were 
taken and tabulated (n = 3).  
Friability test  
The friability of the tablets was determined in Roche 
Friabilator. Five tablets were weighed accurately and 
placed in the tumbling chamber and rotated at 25 rpm 
for a period of 4 min. Tablets were taken and again 
weighed. The percentage weight loss was determined by 
using formula given below. The experiment was 
repeated for three times and average was noted.  
%Fraiability
=
Initial weight of tablets − Final weight of tablet
Initial weight of tablets
x100 
 
Table II: Composition of coating solution  
Eudragit S100 and Eudragit L100 1:1 , 1: 0.5 , 1:2 
 
Determination of drug content  
Five prednisolone tablets were crushed into powder in a 
mortar and powdered equivalent to prednisolone dose 
was taken in a volumetric flask containing distilled 
water and kept aside with constant shaking on a rotary 
shaker for 7-10 h to extract the total drug present in the 
tablet. Then the absorbance of the solutions was 
measured after suitable dilution at 245 nm against 
distilled water as blank. Averages of triplicate readings 
were taken. The content of drug was calculated using 
slope from calibration curve.  
In vitro dissolution study  
The in vitro dissolution study was performed in three 
different buffers of pH 0.1N HCL for 2 h and pH 7.4 for 
3 h and pH 6.4 for 10 h  in order to mimic from mouth 
to colon. The drug release study were carried out in pH 
O.1N HCL in USP dissolution test apparatus of 900 ml 
fluid (Apparatus 1, 100 rpm, 37°C) at regular interval 
sample is withdrawn and suitable dilutions are made and 
estimated for amount of drug release by measuring 
absorbance of sample in UV spectropho-tometer at the 
λmax of 245 nm. At the end of study dissolution 
medium were replaced with Sorenson phosphate buffer 
of pH 7.4 and continued the drug release study for 3 h. 
The samples were withdrawn at regular intervals and 
diluted with respective dissolution medium and 
estimated the drug release by measuring the sample 
absorbance at λ max of the drug in UV 
spectrophotometer. 
 
RESULT & DISCUSSION 
Based on the result of Pre – compression tests, all the 
formulation showed angle of repose ranging from 27.5° 
to 36.30°, indicating a good flow property and Carr’s 
index range indicates compressibility of the granules is 
fairly passable. 
Colon targeted matrix tablet are developed by using 
carrier sterculia gum, ethyl cellulose and carbopol along 
with coating (Eudragit S100 and Eudragit S100). 
Granules are evaluated for rheological properties. The 
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formulation prepared has a ratio in 3 different ways. The 
formulation of F1 and F2 is 1:1, F3 and F4 is 1:0.5 and 
F5 and F6 is 1:2. The ratio difference is between 
Natural Polymer and Synthetic Polymer.   Based on In 
vitro drug release study, formulation 
F4>F3>F2>F1>F6>F5, the drug release found to be 
85.46, 82.03, 78.59, 67.34, 62.05 and 56.14 
respectively. According to Drug release profile founded 
that drug release is highest in F4 formulation. 
Table III: Precompressional granules parameter  
Parameter Prednisolone granules  
Bulk Density (gm/cm2) 0.43±0.01- 0.67±0.06 
Tapped Density (gm/cm2)  0.49±0.03-0.71±0.09 
Compressibility Index 5.3±0.40-14.38±2.97 
Hausner’s Ratio 1.20±0.08-1.24±0.21 
Angle of repose 24.87±0.3-27.22±0.20 
 
Table IV: Post compressional parameters  
Formulation parameter Core Prednisolone tablet  
Weight Variantion (mg) 502.24±0.02-502.65±0.57 
Hardness (kg / cm2) 6.8±0.18 – 7.4±0.14 
Thickness (mm) 35.3±0.04-5.9±0.11 
% Friability  0.40±0.04-0.58±0.15 
Drug content uniformity 93±0.12-98±.14 
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